pravastatin has been researched along with 11-dehydro-thromboxane b2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arpaia, G; Bonfardeci, G; Cimminiello, C; Lorena, M; Merlo, B; Milani, M | 1 |
| Arpaia, G; Bonfardeci, G; Cimminiello, C; Lorena, M; Milani, M; Soncini, M | 1 |
1 trial(s) available for pravastatin and 11-dehydro-thromboxane b2
| Article | Year |
|---|---|
Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lipids; Male; Middle Aged; Placebos; Pravastatin; Single-Blind Method; Thromboxane A2; Thromboxane B2; Thromboxanes; Triglycerides | 1995 |
1 other study(ies) available for pravastatin and 11-dehydro-thromboxane b2
| Article | Year |
|---|---|
Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia.
Topics: Anticholesteremic Agents; Cholesterol; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Indoles; Lipids; Male; Middle Aged; Pravastatin; Thromboxane B2 | 1996 |